No Link Between Anti-Nausea Drug, Hea... (R SOURCE: American Society of An...)

(Date:1/8/2009)...t risk may not be accurate in some cases , ...ies, from the United States and the Netherlands, q...shed Framingham Risk Score in predicting heart dis... score, based on findings of a decades-long study ... assess risk on the basis of seven factors: age, g...

(Date:1/8/2009)...re-USNewswire/ -- Today, the National Hospice and ...tional leadership organizations issued a consensus...e and protection of the Medicare Hospice Benefit. ...s unified message about end-of-life care are the A...cine, Hospice and Palliative Nurses Association, N...

(Date:1/8/2009)...anizations offers five action steps to improve res...wire/ -- Despite the recent three-hour cease fires...s to residents of the Palestinian territory, upwar...ean water and medical help. U.S.-based internation...egion see this arrangement to allow sporadic deliv...

(Date:1/8/2009)...urface of cancer cells are keys to the development...ing the spread of certain types of cancers called ...n and lung, among others. Armed with a new two-ye...Research, an Illinois-based philanthropic foundati...nd her co-workers at the Moores Cancer Center at t...

Breaking Medicine News(10 mins):Health News:Studies Challenge Framingham Risk Score 2 Health News:Studies Challenge Framingham Risk Score 3 Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 2 Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 3 Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 4 Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 5 Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 6 Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 7 Health News:Temporary Cease Fires Not Enough for Humanitarian Aid Groups Working in Gaza 2 Health News:Temporary Cease Fires Not Enough for Humanitarian Aid Groups Working in Gaza 3 Health News:Novel prostate cancer vaccine taking aim at cancer cell 'sweet spot' 2

[0] Studies Challenge Framingham Risk Score [0] National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future [0] Temporary Cease Fires Not Enough for Humanitarian Aid Groups Working in Gaza [0] Novel prostate cancer vaccine taking aim at cancer cell 'sweet spot'

... as a measure for weight reduction may have the po...of the most common procedures to control morbid ob...e size of the stomach and allows the food to pass ...gether with psychological and behavioral support, ...

...e disease of the substantia nigra ,an area in the ... and its symptoms documented in 1817 by the Britis... biochemical changes in the brain of patients were...re identified only recently, others still remain a...

...who had long earlier published their findings on s...ving ADHD, have come up with the results from the ... association between the two. The follow up data ...ticipants of the original study who had snored reg...

...al Agency for Research on Cancer (IARC) in Lyon, F...kers who are exposed to chronic low doses of radia...cer. This is the largest study ever conducted in 1...rkers. It was estimated that the chronic exposure ...

Other Medicine News:Health News:Re –growing Brain cells destroyed by Parkinson’s disease 2

Gastric bypass surgery reduces risk of heart disease Re –growing Brain cells destroyed by Parkinson’s disease Children who snore may be hyperactive by nature Low dose Radiation Exposure May Cause Cancer

(Date:1/8/2009)..., Mass. and COLUMBUS, Ohio, Jan. 8 ...prietary nucleic acid assays, today announced that...al Quantitative Assay are complete. , , Under ...linearity, specificity and reproducibility and rob...termined. The data obtain agreed with internally g...

(Date:1/7/2009)...Tenn., Jan. 7 Scientist... a high likelihood of relapse in children with acu...archers caution that further research is needed to... or IKAROS, lead to leukemia relapse, the findin...nostic tests to assess the risk of treatment failu...

(Date:1/7/2009)...Several Products in Development Based On Osteotech...ate Natural BioRegeneration; FDA Filing Anticipate...an. 7 Osteotech, Inc. ...of biologic products for regenerative healing, ann...cal trial for its DuraTech(TM) BioRegeneration Mat...

(Date:1/6/2009)...xpands on Successful Results from prior U.S., U.K....wire/ -- Vital Therapies, Inc. (VTI), a developmen...ounced patient enrollment has begun for a randomiz...al that will study the Extracorporeal Liver Assist...ute Liver Failure (ALF) under three protocols. The...

Breaking Medicine Technology:Verification Studies of IntelligentMDx's Proprietary Molecular Diagnostic Assay Process Have Been Completed 2 Verification Studies of IntelligentMDx's Proprietary Molecular Diagnostic Assay Process Have Been Completed 3 Gene Abnormality Found to Predict Childhood Leukemia Relapse 2 Gene Abnormality Found to Predict Childhood Leukemia Relapse 3 Gene Abnormality Found to Predict Childhood Leukemia Relapse 4 Gene Abnormality Found to Predict Childhood Leukemia Relapse 5 Gene Abnormality Found to Predict Childhood Leukemia Relapse 6 Osteotech Initiates Pivotal Clinical Trial for DuraTech(TM) BioRegeneration Matrix 2 Osteotech Initiates Pivotal Clinical Trial for DuraTech(TM) BioRegeneration Matrix 3 ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 2 ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 3 University of Pennsylvania study reveals inconspicuous hosts in the Lyme disease epidemic 7233 1 University of Pennsylvania study reveals inconspicuous hosts in the Lyme disease epidemic 7233 2 SEIU Endorses Anderson Perea and Perea in Fresno 7229 1 SEIU Endorses Anderson Perea and Perea in Fresno 7229 2 FDA Sunscreen Labeling Decision Delayed Another Month Leading U S Physician to Say Enough Is Enough 7225 1 FDA Sunscreen Labeling Decision Delayed Another Month Leading U S Physician to Say Enough Is Enough 7225 2 Neptune Technologies 26 Bioressources Inc Secures Access to Nationwide Consumer Mass Market in the United States 2013 1 Neptune Technologies 26 Bioressources Inc Secures Access to Nationwide Consumer Mass Market in the United States 2013 2 Neptune Technologies 26 Bioressources Inc Secures Access to Nationwide Consumer Mass Market in the United States 2013 3

[0] Verification Studies of IntelligentMDx's Proprietary Molecular Diagnostic Assay Process Have Been Completed [1] Gene Abnormality Found to Predict Childhood Leukemia Relapse [0] Osteotech Initiates Pivotal Clinical Trial for DuraTech(TM) BioRegeneration Matrix [0] ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers

...--(BUSINESS WIRE)--Jun 12, 2007 - Critical,Therape...lication,of data from a pivotal Phase III clinical... tablets in the June 2007 issue of the,Journal of ... Drug,Administration (FDA) on May 30, 2007. Critic...rtner Dey, L.P. (DEY), expects to,begin marketing ...

...ted at EULAR Confirms Efficacy with Either Every,T... June 2007 - 7:00 am CET - New pivotal data,(RAPID...ongress of,Rheumatology (EULAR) show that Cimzia (...anti-TNF, combined with methotrexate,therapy has a...s,and symptoms of active rheumatoid arthritis (RA)...

Other Medicine Technology:Critical Therapeutics Announces the Publication of Data for ZyfloCR,(Zileuton) Extended-Release Tablets in the Journal of Asthma 2 Critical Therapeutics Announces the Publication of Data for ZyfloCR,(Zileuton) Extended-Release Tablets in the Journal of Asthma 3 Critical Therapeutics Announces the Publication of Data for ZyfloCR,(Zileuton) Extended-Release Tablets in the Journal of Asthma 4 Critical Therapeutics Announces the Publication of Data for ZyfloCR,(Zileuton) Extended-Release Tablets in the Journal of Asthma 5 Cimzia Effective in Reducing Signs and Symptoms of Rheumatoid,Arthritis 2 Cimzia Effective in Reducing Signs and Symptoms of Rheumatoid,Arthritis 3 Cimzia Effective in Reducing Signs and Symptoms of Rheumatoid,Arthritis 4 Cimzia Effective in Reducing Signs and Symptoms of Rheumatoid,Arthritis 5 Cimzia Effective in Reducing Signs and Symptoms of Rheumatoid,Arthritis 6 Cimzia Effective in Reducing Signs and Symptoms of Rheumatoid,Arthritis 7 Cimzia Effective in Reducing Signs and Symptoms of Rheumatoid,Arthritis 8

Critical Therapeutics Announces the Publication of Data for ZyfloCR,(Zileuton) Extended-Release Tablets in the Journal of Asthma Cimzia Effective in Reducing Signs and Symptoms of Rheumatoid,Arthritis

The Fluoroskan Ascent, a dedicated microplate fluorometer, offers high sensitivity for a wide variety of fluorometric applications.

DyNA Quant™ 200 is a fixed wavelength fluorometer for 365 nm excitation and 460 nm emission. The spectral characteristics are specifically designed for the detection of double-stranded DNA using

The VICTOR² D fluorometer is suitable for clinical assays based on fluorescence or time-resolved fluorescence from a wide variety of plates.

Liquid, ready-to-use, bar-coded Olympus reagents are convenient, economical easy-to-use and reliable. This is one of 122 tests standardized for use on the Olympus AU400e, AU640e, AU2700, and AU5400 C

Medicine Products:

Fluoroskan Ascent DyNA Quant™ 200 Fluorometer VICTOR² D fluorometer LDL Cholesterol, Direct Test

No Link Between Anti-Nausea Drug, Hea...(R SOURCE: American Society of An...),Health